American Thoracic Society Annual International Congress

Bibliography

• WENZEL SE: Asthma: defining of the persistent adult phenotypes. Lancet (2006) 368:804-813.
   PubMed Web of Science ®Google Scholar
• NATIONAL INSTITUTES OF HEALTH: Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report. US Department of Health and Human Services, Bethesda, USA (2006).
   Google Scholar
• OHAMEJE NU, LOVELESS JW, SAINI SS: Atopic dermatitis or hyper-IgE syndrome? Allergy Asthma Proc. (2006) 27(3):289-291.
   PubMed Web of Science ®Google Scholar
• VIGO PG, GIRGIS KR, PFUETZE BL, CRITSCHLOW ME, FISHER J, HUSSAIN I: Efficacy of anti-IgE therapy in patients with atopic dermatitis. J. Am. Acad. Dermatol. (2006) 55(1):168-170.
   PubMed Web of Science ®Google Scholar
• WILLIAMS PB, SHEPPARD JD Jr: Omalizumab: a future innovation for treatment of severe ocular allergy? Expert Opin. Biol. Ther. (2005) 5(12):1603-1609.
   PubMed Web of Science ®Google Scholar
• BOYCE JA: Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J. Allergy Clin. Immunol. (2006) 117:1415-1418.
   PubMed Web of Science ®Google Scholar
• ERIN EM, LEAKER BR, NICHOLSON GC et al.: The effects of a monoclonal antibody directed against TNF-α in asthma. Am. J. Respir. Crit. Care Med. (2006) 174(7):753-762.
   PubMed Web of Science ®Google Scholar
• HOWARTH P, BABU KS, ARSHAD HS et al.: Tumour necrosis factor (TNF-α) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax (2005) 60(12):1012-1018.
   PubMed Web of Science ®Google Scholar
• COX G, THOMSON NC, RUBIN AS et al.: Asthma control during the year after bronchial thermoplasty. N. Engl. J. Med. (2007) 356:1327-1337.
   PubMed Web of Science ®Google Scholar
• CALVERLEY PMA, ANDERSON JA, CELLI BR et al.: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. (2007) 356(8):775-789.
   PubMed Web of Science ®Google Scholar
• TILLIE-LEBLOND I, MARQUETTE CH, PEREZ T et al.: Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann. Intern. Med. (2006) 144(6):390-396.
   PubMed Web of Science ®Google Scholar
• RUTSCHMANN OT, CORNUZ J, POLETTI PA et al.: Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease? Thorax (2007) 62(2):121-125.
   PubMed Web of Science ®Google Scholar
• DAHL M, VESTBO J, LANGE P, BOJESEN SE, TYBJAERG-HANSEN A, NORDESTGAARD BG: C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. (2007) 175(3):250-255.
   PubMed Web of Science ®Google Scholar
• WINTON T, LIVINGSTON R, JOHNSON D et al.: Vinorelbine puls cisplatin versus observation in resected non-small-cell lung cancer. N. Engl. J. Med. (2006) 352:2589-2597.
   Web of Science ®Google Scholar
• HERTH FJ, EBERHARDT R, VILMANN P, KRASNIK M, ERNST A: Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax (2006) 61(9):795-798.
   PubMed Web of Science ®Google Scholar
• MARKIS D, SCHERPEREEL A, LEROY S et al.: Electromagnetic navigation diagnostic bronchoscopy for small peripheral lung lesions. Eur. Respir. J. (2007) 29(6):1187-1192.
   PubMed Web of Science ®Google Scholar
• SHINAGAWA N, YAMAZAKI K, ONODERA Y et al.: Virtual bronchoscopic navigation system shortens the examination time – feasibility study of virtual bronchoscopic navigation system. Lung Cancer (2007) 56(2):201-206.
   PubMed Web of Science ®Google Scholar
• TORRES A, LE BERRE M, CHOUDHRI S, ARVIS P: Moxifloxacin vs ceftriaxone/levofloxacin in hospitalized patients with community-acquired pneumonia (CAP), PSI class IV and V: a MOTIV study subanalysis. Am. J. Respir. Crit. Care Med. (2007) 163:A107.
   Google Scholar
• SPINDLER C, ORTQVIST A: Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia. Eur. Respir. J. (2006) 28(4):816-823.
   PubMed Web of Science ®Google Scholar
• MANDELL LA, WUNDERINK RG, ANZUETO A et al.: Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. (2007) 44(Suppl. 2):S27-S72.
   PubMed Web of Science ®Google Scholar
• BRITISH THORACIC SOCIETY AND STANDARDS OF CARE COMMITTEE: BTS guidelines for the management of community acquired pneumonia in adults. Thorax (2001) 56(Suppl. 4):IV1-IV64.
   PubMed Web of Science ®Google Scholar
• MOUSSAOUI EL R, BORGIE DE CA, BROEK VAN DEN PJ et al.: Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ (2006) 332(7554):1355-1362.
   PubMedGoogle Scholar
• LI J, SAVRANSKY V, NANAYAKKARA A, SMITH PL, O'DONNELL CP, POLOTSKY VY: Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J. Appl. Physiol. (2007) 102(2):557-563.
   PubMed Web of Science ®Google Scholar
• SAVRANSKY V, NANAYAKKARA A, LI J et al.: Chronic intermittent hypoxia induces atherosclerosis. Am. J. Respir. Crit. Care Med. (2007) 175(12):1290-1297.
   PubMed Web of Science ®Google Scholar
• MULGREW AT, FOX N, AYAS NT, RYAN CF: Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study. Ann. Intern. Med. (2007) 146(3):157-166.
   PubMed Web of Science ®Google Scholar
• GILLISSEN A: Meeting highlights of the European respiratory society annual congress (02 – 06 September 2006), Munich, Germany. Expert Opin. Pharmacother. (2007) 8(5):711-717.
   PubMed Web of Science ®Google Scholar
• GILLISSEN A, WIRTZ H, HOHEISEL GB: Paradigmenwechsel in der Therapieempfehlung des Asthma bronchiale. Med. Klinik (2007) 102(5):399-403.
   Google Scholar